CAD 0.14
(-6.67%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 152.54 Million USD | -18.7% |
2022 | 187.64 Million USD | 9.4% |
2021 | 171.51 Million USD | -44.83% |
2020 | 310.88 Million USD | 39.44% |
2019 | 222.94 Million USD | 60.24% |
2018 | 139.13 Million USD | 615.19% |
2017 | 19.45 Million USD | 135.15% |
2016 | 8.27 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 129.79 Million USD | -8.45% |
2024 Q1 | 141.77 Million USD | -7.06% |
2023 Q4 | 152.54 Million USD | -6.91% |
2023 FY | 152.54 Million USD | -18.7% |
2023 Q1 | 175.97 Million USD | -6.22% |
2023 Q2 | 176.58 Million USD | 0.35% |
2023 Q3 | 163.86 Million USD | -7.2% |
2022 Q2 | 153.01 Million USD | -4.86% |
2022 Q4 | 187.64 Million USD | 33.54% |
2022 FY | 187.64 Million USD | 9.4% |
2022 Q1 | 160.82 Million USD | -6.23% |
2022 Q3 | 140.51 Million USD | -8.17% |
2021 Q1 | 295.57 Million USD | -4.92% |
2021 FY | 171.51 Million USD | -44.83% |
2021 Q4 | 171.51 Million USD | -40.15% |
2021 Q3 | 286.58 Million USD | 0.24% |
2021 Q2 | 285.88 Million USD | -3.28% |
2020 Q2 | 357.59 Million USD | 87.98% |
2020 Q1 | 190.23 Million USD | -14.67% |
2020 FY | 310.88 Million USD | 39.44% |
2020 Q4 | 310.88 Million USD | -5.92% |
2020 Q3 | 330.46 Million USD | -7.59% |
2019 Q3 | 180.98 Million USD | 15.11% |
2019 Q2 | 157.22 Million USD | -8.41% |
2019 Q1 | 171.66 Million USD | 23.38% |
2019 FY | 222.94 Million USD | 60.24% |
2019 Q4 | 222.94 Million USD | 23.18% |
2018 Q3 | 110.38 Million USD | 300.59% |
2018 Q1 | 24.27 Million USD | 24.78% |
2018 Q2 | 27.55 Million USD | 13.51% |
2018 Q4 | 139.13 Million USD | 26.05% |
2018 FY | 139.13 Million USD | 615.19% |
2017 Q4 | 19.45 Million USD | 0.0% |
2017 FY | 19.45 Million USD | 135.15% |
2016 FY | 8.27 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aurora Cannabis Inc. | 838.67 Million CAD | 81.811% |
Avicanna Inc. | 21.97 Million CAD | -594.312% |
Avant Brands Inc. | 82.55 Million CAD | -84.79% |
Cardiol Therapeutics Inc. | 36.7 Million CAD | -315.656% |
Crescita Therapeutics Inc. | 24.59 Million CAD | -520.164% |
Knight Therapeutics Inc. | 945.49 Million CAD | 83.866% |
MediPharm Labs Corp. | 63.93 Million CAD | -138.591% |
OrganiGram Holdings Inc. | 298.45 Million CAD | 48.887% |
Canopy Growth Corporation | 1.3 Billion CAD | 88.269% |
Willow Biosciences Inc. | 6.67 Million CAD | -2186.048% |
Auxly Cannabis Group Inc. | 261.9 Million CAD | 41.754% |